• Corporate
  • About Medicago
  • Corporate strategy
  • Management team
  • Board of directors
  • Scientific advisory council
  • Current partnerships
• Technologies
  • Medicago technologies
  • Vaccines
    • Influenza
    • Pandemic market
  • Why Plants?
    • Tobacco
    • Alfalfa
  • Why Proficia™?
  • Why VLPs?
    • VLPExpress
  • Patents/IP
  • Scientific publications
• Manufacturing
  • Facility overview
  • Advantages
  • How does it work?
• Products
  • Product pipeline
  • Pandemic flu vaccine
  • Recent results
  • Partnering opportunities
• Investors
  • Why invest
  • Stock quote
  • Events & presentations
  • Financial Reports
  • Stockholder information
  • Analyst Coverage
  • Corporate governance
  • FAQs
  • Glossary of terms
  • IR contact
  • RSS feeds
• News
  • News releases
  • Medicago in the news
  • Useful links
• Partnerships
  • Current partnerships
  • Partnership opportunities

News

News releases Medicago in the news Useful links

Normal

News Releases

Press Release RSS

2010 2009 2008 2007 2006

Date	Subject
Nov 28, 2006	Nov 28, 2006 Medicago Reports 2006 Third Quarter Results
Aug 30, 2006	Aug 30, 2006 MEDICAGO INC. COMPLETES ITS INITIAL PUBLIC OFFERING FOR GROSS PROCEEDS OF $2,003,834
Aug 30, 2006	Aug 30, 2006 Medicago Reports Second Quarter Financial and Operating Results
Aug 08, 2006	Aug 08, 2006 Medicago and PBL sign license agreements for PBL's bipartite expression and related technologies
Aug 02, 2006	Aug 02, 2006 MEDICAGO INC. ANNOUNCES THE FILING OF A FINAL PROSPECTUS IN CONNECTION WITH ITS INITIAL PUBLIC OFFERING

Français

• HOME
• CAREERS
• TERMS OF USE
• CONTACT US

Powered By Q4 Web Systems 3.5.8.1201